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Gregory L. Moneta, MD, Abstracts Section EditorLong-term predictors of descending aorta aneurismal change in
patients with aorta dissections
Song J-N, Kim S-D, Kim J-H, et al. J Am Coll Card 2006;50:799-804.
Conclusion: Aneurysmal dilatation as a late manifestation of aortic
dissection is most likely to take place in the upper thoracic aorta. Aneurysmal
dilatation of the upper thoracic aorta is predicted by a large false lumen
diameter on the initial computed tomography (CT) scan.
Summary: After acute aortic dissection, late aneurysmal dilatation of
the aorta is a significant complication. The authors sought to demonstrate
the long-term natural history of descending aorta dilatation after acute aortic
dissection. They also sought to identify early predictors of late aneurysmal
change in the dissected aorta. Contrast-enhanced CT scans for acute aortic
dissection were performed in 100 patients. There were 51 patients with
DeBakey type 1 dissections and 49 patients with DeBakey type 3 dissections.
The patients with type 1 dissections underwent ascending aortic surgery
24 hours of diagnosis.
Clinical follow-up was for 53  26 months, and CT scans were
repeated at a mean of 31  27 months. Aortic dilatation to 60 mm
occurred in 14.4% of the upper thoracic descending aortas, 8.2% of the
middle descending thoracic aortas, 4.1% in the lower descending thoracic
aortas, and in 3.1% of the abdominal aortas. A repeat CT scan was done in 53
patients2 years after the initial dissection. On the basis of these scans, rates
of aortic enlargement per year at the upper, middle, and lower thoracic, and
abdominal aorta levels were 3.43  3.66, 3.21  2.70, 2.62  2.19, and
1.93  3.66 mm, respectively (P  .01). Aneurysms developed in 28%.
Predictors of late aneurysmal change included the initial false lumen diam-
eter of the upper thoracic aorta, aortic diameter in the middle thoracic aorta,
and Marfan syndrome. A22-mm initial false lumen diameter of the upper
thoracic aorta predicted late aneurysmal degeneration with a sensitivity of
100% and a specificity of 76%. The 42 patients with initial upper thoracic
aorta false lumen diameters22 mm also had a higher rate of the combina-
tion of aneurysm formation and death (P  .001).
Comment: The study suggests patients with acute aortic dissection
with large false lumens of their upper thoracic aorta may be ones where
prophylactic stent grafting might be beneficial. A European trial that has
either just begun, or will begin soon, is investigating the impact of stent
grafting on uncomplicated acute type 3 aortic dissections, the ADSORB
(Acute Dissection Stenting or BestMedical Treatment study). Results of this
trial will, hopefully, help determine the optimal role of stent grafting for
acute aortic dissection.
Early results after staged hybrid repair of thoracoabdominal aortic
aneurysms
Lee WA, Brown MP, Martin TD, Seeger JM, et al. J Am Coll Surg
2007;2005:420-31.
Conclusion: The hybrid approach of thoracoabdominal aneurysm
(TAA) repair can be performed with relatively few technical complications,
but morbidity and mortality rates remain significant.
Summary: The authors reviewed the morbidity and mortality associ-
ated with the hybrid approach of TAA repair. This is a retrospective review of
17 patients (mean age, 69 15 years, 76% men), who underwent renal and
visceral revascularization as a first stage of a hybrid repair of a TAA. The
TAAs treated in this study included two Crawford extent type II, eight type
III, and seven type IV. Perioperative mortality and complication rates
associated with the debranching portion of the procedure were 24% and
25%, respectively. The mean intensive care unit stay and hospital stay were 7
12 days and 22 33 days, respectively. The mean delay between the staged
procedures was 27  27 days. The thoracic stent graft (stage 2) was placed
in 12 (92%) of the 13 patients who survived the initial portion of the
procedure. No additional deaths or postoperative complications were asso-
ciated with the second stage of the procedure. After the second stage,
patients did not require intensive care unit stay, and the overall length of stay
after the procedure was 2  2 days. Postoperative follow-up among 11
patients completing both stages was 8  12 months, with no additional
deaths during follow-up. Primary patency for renal and visceral grafts was
96% (54 of 56).
Comment:The hybrid approach to TAA repair is difficult operation for
both the patient and the surgeon. If complete debranching of the aorta is
performed, and a conduit is placed for subsequent placing of the thoracic
endograft, operative times of 6 to 9 hours are expected. Mortality and
morbidity rates are significant. The hybrid approach to TAA repair, although
a tribute to surgical technical expertise, is not likely to be the final word in the
surgical treatment of patients with TAAs. We await the availability of anoff-the-shelf branched stent graft that can be implanted with a reasonable
and not exceptional level of technical expertise.
Effects of torcetrapib in patients at high risk for coronary events
Barter PJ, Caulfield M, Eriksson M, and the ILLUMINATE Investigators.
N Engl J Med 2007;357:2109-22.
Conclusion: Torcetrapib therapy, which increases high-density li-
poprotein (HDL), results in an increased risk of mortality and morbidity.
Summary: Cholesteryl ester transfer protein (CETP) results in
transfer of cholesteryl esters from HDL to other lipoproteins. Inhibiting
CETP therefore results in increased HDL cholesterol levels and results in
decreased low-density lipoprotein (LDL) cholesterol levels. Given these
possible antiatherogenic effects, it would seem reasonable that torce-
trapib, an inhibitor of CETP, would have a favorable effect on morbidity
and mortality. To test this hypothesis, the authors conducted a double-
blind randomized study of 15,067 patients considered at high cardiovas-
cular risk. Patients were treated with atorvastatin alone or torcetrapib
plus atorvastatin. The primary outcome was time to the first major
cardiovascular event, which was defined as death from coronary heart
disease, stroke, or hospitalization for unstable angina or nonfatal myo-
cardial infarction.
In patients receiving torcetrapib therapy, after 12 months, there was an
increase of 72.1% in HDL and a decrease of 24.9% in LDL cholesterol
compared with baseline (P .001), and there was also an increase in systolic
blood pressure of 5.4 mmHg. Serum sodium, bicarbonate, and aldosterone
levels all also increased in patients treated with torcetrapib (P  .001).
Patients treated with torcetrapib had an increased risk of cardiovascular
events (hazard ratio, 1.25; 95% confidence interval, 1.09-1.44; P .001) as
well as an increase of death from any cause (hazard ratio 1.58; 95% confi-
dence interval, 1.14-2.19; P  .006). Post hoc analysis indicated there was
an increased risk of death in patients with torcetrapib therapy who had
increases in bicarbonate or reductions in potassium levels greater than the
median change.
Comment: This study documented a number of off-target pharmaco-
logic effects of torcetrapib. The increase of systolic blood pressure, as well as
the metabolic effects, may have negated the effects of improvement in HDL
and LDL levels induced by torcetrapib. This study, therefore, neither
validates nor invalidates the possibility that raising HDL cholesterol
levels by inhibition of CETP can be cardio productive. As the authors
point out in the discussion of the article, this hypothesis can only be
tested by use of a CETP inhibitor that does not share the off-target
pharmacologic effects of torcetrapib.
Childhood body-mass index and the risk of coronary heart disease in
adulthood
Baker JL, Olsen LW, Sorensen TIA. N Engl J Med 2007;357:2329-37.
Conclusion: Increases in the bodymass index (BMI) during childhood
are associated with an increased risk of coronary heart disease (CHD) in
adulthood.
Summary: Children are becoming overweight at progressively
younger ages, with 19% of children aged 6 to 11 years in the United States
considered overweight (Int J Obes Relat Metab Disord 2002;26[suppl 4]:S2-
S4, and JAMA 2006;295:1549-55). In this study, the authors sought to
determine long-term effects of increased weight in childhood CHD. Au-
thors studied the association between BMI in children aged 7 to 13 years and
CHD in adults aged 25 years. Data were analyzed with and without
adjustment for birth weight.
Subjects were derived from a cohort of 276,845 school children in
Denmark whose height and weight measurements were available. National
registries were used to determine CHD events. There were 5,063,622
person-years of follow-up. A total of 10,235 adult men and 4318 adult
women had a diagnosis of CHD or died of CHD for whom childhood BMI
data were also available. Risk of fatal and nonfatal events and any CHD event
in the adults were positively associated with BMI from 7 to 13 years of age
for boys and from 10 to 13 years of age for girls. Risk increased across the
entire BMI distribution, and associations were linear for each age. Risk also
increased as the age of the child increased. Adjustment for birth weight
strengthened the results.
Comment: The data provide some quantitative information on the
adverse effect of childhood obesity on future health. The magnitude of
increased risk of CHD is relatively modestly increased in children at 7 years
of age and dramatically increases further by age 13. Parents must somehow
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Prevention of perioperative thromboembolism in patients with atrial
fibrillation
Beldi G, Beng L, Siegel G, Fisch-Knaden S, et al. Brit J Surg 2007;94:
1351-5.
Conclusion: Compared with postoperative anticoagulation with low-
molecular-weight heparin (LMWH), postoperative anticoagulation with
therapeutic unfractionated heparin (UFH) in patients receiving long-term
anticoagulation is associated with an increased risk of bleeding and does not
reduce the risk of thromboembolism.
Summary: This was a retrospective study designed to test the safety
and efficacy of two methods of prophylaxis for perioperative thromboem-
bolism in patients with atrial fibrillation (AF), which was present in 1.9% of
patients undergoing 14,801 operative procedures. Patients with AF who
were not receiving oral anticoagulation (n  146) were placed on the
LMWHnadroparin before and after surgery (40U/kg). Those patients with
AF who were on anticoagulation before surgery (n  136) were placed on
intravenous UFH postoperatively at a dose to maintain therapeutic levels.
Arterial or venous thromboembolism occurring in the perioperative
period was independent of pre-existing risk factors. Atrial or venous throm-
boembolism occurred in 4.6% of patients, without significant differences
between the perioperative use of LMWH or UFH (P  .78). Thromboem-
bolism was significantly associated with increased perioperative mortality
(odds ratio, 9.5; 95% confidence interval, 2.5-35.8, P  .001). Postopera-
tive bleeding occurred in 4.8% of patients treated with LMWH and in 17.6%
of patients treated with UFH (P  .001).
Comment: Patients on long-term anticoagulation for AF often must
have anticoagulation interrupted for an operative procedure. During this
time, anticoagulation is generally “bridged” with heparin until vitamin K
antagonists can be restarted. The study is important in that it indicates this
“bridging” of anticoagulation is probably best performed with LMWH,
rather than UFH. Although this was a study of general surgical patients, it is
likely that differences may be even more dramatic in patients undergoing
vascular surgery.
Preoperative cerebral hemodynamic impairment and reactive oxygen
species produced during carotid endarterectomy correlate with devel-
opment of postoperative cerebral hyperperfusion
Suga Y, Ogasawara K, Saito H, et al. Stroke 2007;38:2712-2717.
Conclusion: Reactive oxygen species, which are produced during
carotid endarterectomy (CEA), and preoperative cerebral hemodynamic
impairment correlate with development of cerebral hyperperfusion after
CEA.
Summary: The authors sought to determine the relationship between
production of reactive oxygen species and preoperative cerebral hemody-
namic impairment with postoperative cerebral hyperperfusion in CEA pa-
tients. Malondialdehyde-modified low-density lipoprotein (MDA-LDL) is a
marker of oxidative damage that can bemeasured in serum samples. Cerebral
hemodynamic impairment can be measured using single-photon emission
computed tomography (SPECT) to assess cerebral blood flow and cerebro-
vascular reactivity with acetazolamide. In this study, 90 patients who under-
went carotid endarterectomy for ipsilateral internal carotid artery stenosis
70% were assessed with MDA-LDL levels, as well as preoperative SPECT.
Hyperperfusion was defined as a cerebral blood flow increase of 100%
compared with preoperative values.
After CEA, hyperperfusion was documented by increased cerebral
blood flow in 12 patients (13%). Logistic regression analysis determined that
reduced preoperative cerebrovascular reactivity (95% confidence interval,
1.053-1.453; P  .0097) and an increase in MDA-LDL after internal
carotid artery clamping (95% confidence interval, 0.862-0.980; P  .0098)
were associated with development of postoperative cerebral hyperperfusion.
Of the 11 patients with reduced preoperative cerebrovascular reactivity and
increased MDA-LDL after internal carotid artery clamping, post-CEA hy-
perperfusion developed in 10, and two of these had cerebral hyperperfusion
syndrome.
Comment: It is known post-CEA hyperperfusion syndrome correlates
with reduced preoperative cerebrovascular reactivity. However, hyperperfu-
sion syndrome does not develop in all patients with reduced preoperative
cerebrovascular reactivity (52% in this study). The addition of MDA-LDL
levels to the preoperative assessment of cerebral blood flow in patients at risk
for post-CEA hyperperfusion syndrome may help more precisely identify
patients at risk for postoperative CEA hyperperfusion syndrome.Involvement of MMPs in the outward remodeling of collateral mesen-
teric arteries
Haas TL, Doyle JL, Distasi MR, et al. Am J Physiol Heart Circ Physiol
2007;293:H2429-37.
Conclusion: Matrix metalloproteinase (MMP) activity is essential to
the remodeling process that leads to luminal expansion associated with
collateral vessel enlargement.
Summary: Shear stress is important in collateral enlargement. Eleva-
tions in shear stress within resistance or conduit arteries result in luminal
expansion. The result is normalization of shear stress and maintenance of
flow to the downstream vasculature. This process involves remodeling of the
extracellular matrix and cellular proliferation; however, specific cellular
events leading to these events are poorly understood. It is known thatMMPs
contribute to the remodeling of the extracellular matrix in vein grafts and
conduit vessels exposed to high flow rates. This study sought to evaluate the
role of MMPs in remodeling of small collateral arteries exposed to increases
in shear stress.
The authors used an established model of outward remodeling of
mesenteric collateral arteries that utilizes ileal arteries of maleWistar rats that
are surgically ligated to produce a collateral-dependent region. They sought
to determine whether MMPs were up-regulated during remodeling and to
test whether MMP activity was required for luminal expansion. After 2 to 7
days, arteries were harvested andMMP9 andMMP2 levels determined using
standard gelatin zymography and immunostaining. At 4 days, membrane
type 1 MMP (MT1-MMP) andMMP2, but not MMP9, protein levels were
elevated in collateral arteries. The elevated MMP proteins, along with their
respective transcriptional activators, were predominately localized to the
smooth muscle layer of the collateral arteries. Doxycycline, a general MMP
inhibitor, prevented luminal expansion of collateral arteries but did not
affect medial growth responses or endothelial cell proliferation.
Comment: This study may serve as the basis of a new approach to
improving distal circulation in situations where the primary conduit arteries
are stenosed or occluded. Perhaps enlargement of collateral vessels through
an MMP mechanism can serve as an alternative to angiogenesis in patients
with severe intermittent claudication or critical limb ischemia.
Increased mortality, postoperative morbidity, and cost after red blood
cell transfusion in patients having cardiac surgery
Murphy GJ, Reeves BC, Rogers CA, et al. Circulation 2007;116:2544-52.
Conclusion: In patients having cardiac surgery, red blood cell (RBC)
transfusion is associated with increased rates of ischemic postoperative
morbidity, infection, and early and late mortality, as well as increased
hospital lengths of stay and hospital costs.
Summary: The authors sought to quantify clinical outcomes and costs
with RBC transfusion in patients having cardiac surgery. Databases for
clinical hematology and blood transfusions were linked with the United
Kingdom population register. Hematocrit information was obtained from
intensive care unit charts. Prespecified primary end points were composite
infection (wound infection, septicemia, or respiratory infection) and isch-
emic outcomes (renal impairment from ischemic injury, myocardial infarc-
tion, or stroke). Resource use, cost, and survival were secondary outcomes.
Regression modeling with adjustment for potential confounding variables
was used to determine associations between transfusion and the primary and
secondary outcomes.
Patients were derived from the Bristol Royal Infirmary database of adult
cardiac surgery patients. This included patients having cardiac surgery from
April 1, 1996, to December 31, 2003. Adjusted odds ratio for ischemic
outcomes (832 of 8518) and for composite infections (737 of 8516) were
3.35 (95% confidence interval [CI], 2.68-4.35) and 3.38 (95% CI 2.60-
4.40) respectively. Relative cost of admission was increased by any transfu-
sion at a rate of 1.4 times for transfusion (95% CI 1.37-1.46), varying from
1.11 for 1 U to 3.35 for 9 U transfused. At any time after operation,
patients with transfusion were less likely to have been discharged from the
hospital (hazard ratio [HR] 0.63; 95% CI, 0.60-0.67) and more likely to
have died (0 to 30 days: HR, 6.69; 95% CI, 3.66-15.1; 31 days to 1 year:
HR, 2.59; 95% CI, 1.68-4.17; 1 year: HR, 1.32; 95% CI, 1.08-1.64).
Comment: Transfusion is known to be strongly associated with infec-
tion. In this study however, transfusion was also strongly associated with
increased hospital costs and poorer long-term prognosis. A most surprising
finding was that ischemic outcomes were made worse by transfusion, incon-
sistent with a widely held belief that RBC transfusion improves tissue
oxygenation. It appears another accepted truth in medicine is once again no
more than a half-truth and probably less than that. In fact, we have a very
poor understanding of the indications for RBC transfusion. These data
certainly imply that we are transfusing too many patients and not only
wasting money but also adversely affecting the patients.
